ReWalk Robotics (Nasdaq:RWLK) announced that it appointed Joseph Turk, Jr. to its board of directors.
The appointment was made effective on April 20.
Turk joins the Marlborough, Massachusetts-based robotic medical technology developer having begun his career at McKinsey and Company before joining Boston Scientific as its director of new business development.
He also held leadership roles — including that of president — at NxStage Medical. He currently serves as EVP and president of the renal therapies group at Fresenius Medical Care North America.
“Being able to improve people’s lives through commercializing novel technologies has been a driving force in my career,” Turk said in a news release. “Working with a mission-driven company with life-changing technologies such as ReWalk is a natural fit. I look forward to contributing my insight to help ReWalk develop successful broad commercialization strategies that enable better health for the disabled community, all within the context of a sustainable business model.”